Analysis of haematological changes in tofacitinib-treated patients with rheumatoid arthritis across phase 3 and long-term extension studies
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Analysis of haematological changes in tofacitinib-treated patients with rheumatoid arthritis across phase 3 and long-term extension studies
Authors
Keywords
-
Journal
RHEUMATOLOGY
Volume 56, Issue 1, Pages 46-57
Publisher
Oxford University Press (OUP)
Online
2016-10-24
DOI
10.1093/rheumatology/kew329
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tofacitinib or adalimumab versus placebo: patient-reported outcomes from a phase 3 study of active rheumatoid arthritis
- (2016) Vibeke Strand et al. RHEUMATOLOGY
- Tofacitinib With Methotrexate in Third-Line Treatment of Patients With Active Rheumatoid Arthritis: Patient-Reported Outcomes From a Phase III Trial
- (2015) Vibeke Strand et al. ARTHRITIS CARE & RESEARCH
- Effects of tofacitinib monotherapy on patient-reported outcomes in a randomized phase 3 study of patients with active rheumatoid arthritis and inadequate responses to DMARDs
- (2015) Vibeke Strand et al. ARTHRITIS RESEARCH & THERAPY
- Assessment of Fatigue in Rheumatoid Arthritis (by Functional Assessment of Chronic Illness Therapy–Fatigue Score) and Its Relation to Disease Activity and Anemia
- (2015) Harpreet Singh et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- THU0258 Oral Start: Effects of the Oral JAK Inhibitor Tofacitinib Monotherapy Versus Methotrexate on Patient-Reported Outcomes in the Phase 3 Oral Start Trial of Active Rheumatoid Arthritis
- (2014) V. Strand et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of interferon- on hematopoiesis
- (2014) A. M. de Bruin et al. BLOOD
- Pro-inflammatory cytokines: Emerging players regulating HSC function in normal and diseased hematopoiesis
- (2014) Cristina Mirantes et al. EXPERIMENTAL CELL RESEARCH
- Safety and Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, for the Treatment of Rheumatoid Arthritis in Open-label, Longterm Extension Studies
- (2014) J. Wollenhaupt et al. JOURNAL OF RHEUMATOLOGY
- Efficacy and safety of tofacitinib as monotherapy in Japanese patients with active rheumatoid arthritis: a 12-week, randomized, phase 2 study
- (2014) Yoshiya Tanaka et al. Modern Rheumatology
- Tofacitinib versus Methotrexate in Rheumatoid Arthritis
- (2014) Eun Bong Lee et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis
- (2013) Joel Kremer et al. ANNALS OF INTERNAL MEDICINE
- Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve-month data from a twenty-four-month phase III randomized radiographic study
- (2013) Désirée van der Heijde et al. ARTHRITIS AND RHEUMATISM
- Effect of tofacitinib, a Janus kinase inhibitor, on haematological parameters during 12 weeks of psoriasis treatment
- (2013) B. Strober et al. BRITISH JOURNAL OF DERMATOLOGY
- Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial
- (2013) Gerd R Burmester et al. LANCET
- Role of neutrophils in systemic autoimmune diseases
- (2013) Mariana J Kaplan ARTHRITIS RESEARCH & THERAPY
- Furthering Our Understanding of Fatigue in Rheumatoid Arthritis
- (2012) S. HEWLETT et al. JOURNAL OF RHEUMATOLOGY
- Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
- (2012) Roy Fleischmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
- (2012) Ronald F. van Vollenhoven et al. NEW ENGLAND JOURNAL OF MEDICINE
- A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone
- (2011) Joel M. Kremer et al. ARTHRITIS AND RHEUMATISM
- Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs
- (2011) Roy Fleischmann et al. ARTHRITIS AND RHEUMATISM
- IL-6 plays an essential role in neutrophilia under inflammation
- (2011) Misato Hashizume et al. CYTOKINE
- Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
- (2011) Kamran Ghoreschi et al. JOURNAL OF IMMUNOLOGY
- Linking interleukin-6 receptor blockade with tocilizumab and its hematological effects using a modeling approach
- (2011) Leonid Gibiansky et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Phase II study of tofacitinib (CP-690,550) combined with methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate
- (2011) Yoshiya Tanaka et al. ARTHRITIS CARE & RESEARCH
- Inhibition of JAK kinases in patients with rheumatoid arthritis: scientific rationale and clinical outcomes
- (2010) Richard J. Riese et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis
- (2010) Debra M Meyer et al. Journal of Inflammation-London
- Fatigue in rheumatoid arthritis: time for a conceptual model
- (2010) S. Hewlett et al. RHEUMATOLOGY
- Measuring fatigue in rheumatoid arthritis: A cross-sectional study to evaluate the Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional questionnaire, visual analog scales, and numerical rating scales
- (2010) Joanna Nicklin et al. ARTHRITIS CARE & RESEARCH
- The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo
- (2009) Joel M. Kremer et al. ARTHRITIS AND RHEUMATISM
- A Semi-Mechanistic Model of CP-690,550-Induced Reduction in Neutrophil Counts in Patients With Rheumatoid Arthritis
- (2009) Pankaj Gupta et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Fatigue is a reliable, sensitive and unique outcome measure in rheumatoid arthritis
- (2009) P. Minnock et al. RHEUMATOLOGY
- Fatigue as experienced by patients with rheumatoid arthritis (RA): A qualitative study
- (2007) Han Repping-Wuts et al. INTERNATIONAL JOURNAL OF NURSING STUDIES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started